Compass Therapeutics annual debt-to-assets ratio
2020
2021
2022
2023
2024
2025
Compass Therapeutics Debt-to-Assets Ratio Growth & History (CMPX)
Compass Therapeutics's debt-to-assets ratio was 0.04 for fiscal 2025.
View full Compass Therapeutics company overviewCompass Therapeutics annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.04 | −0.00 | −5.27% |
| 2024 | 2024-12-31 | 0.05 | 0.04 | +327.71% |
| 2023 | 2023-12-31 | 0.01 | −0.00 | −24.86% |
| 2022 | 2022-12-31 | 0.01 | −0.01 | −44.01% |
| 2021 | 2021-12-31 | 0.03 | −0.15 | −85.40% |
| 2020 · Dec 31 | 2020-12-31 | 0.18 | — | — |
Compass Therapeutics quarterly debt-to-assets ratio
Q4.19
Q1.21
Q2.21
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.05 | −0.03 | −40.31% |
| Q1 2026 | 2026-03-31 | 0.05 | −0.00 | −1.69% |
| Q4 2025 | 2025-12-31 | 0.04 | −0.00 | −5.27% |
| Q3 2025 | 2025-09-30 | 0.04 | −0.00 | −7.82% |
| Q2 2025 | 2025-06-30 | 0.08 | 0.08 | +1113.83% |
| Q1 2025 | 2025-03-31 | 0.05 | 0.04 | +453.59% |
| Q4 2024 | 2024-12-31 | 0.05 | 0.04 | +327.71% |
| Q3 2024 | 2024-09-30 | 0.05 | 0.03 | +283.75% |
| Q2 2024 | 2024-06-30 | 0.01 | −0.01 | −46.55% |
| Q1 2024 | 2024-03-31 | 0.01 | −0.01 | −37.61% |
| Q4 2023 | 2023-12-31 | 0.01 | −0.00 | −24.86% |
| Q3 2023 | 2023-09-30 | 0.01 | −0.01 | −52.28% |
| Q2 2023 | 2023-06-30 | 0.01 | −0.01 | −47.50% |
| Q1 2023 | 2023-03-31 | 0.01 | −0.01 | −45.32% |
| Q4 2022 | 2022-12-31 | 0.01 | −0.01 | −44.01% |
| Q3 2022 | 2022-09-30 | 0.03 | −0.21 | −89.21% |
| Q2 2022 | 2022-06-30 | 0.02 | −0.23 | −90.08% |
| Q1 2022 | 2022-03-31 | 0.03 | −0.23 | −89.99% |
| Q4 2021 | 2021-12-31 | 0.03 | −0.15 | −85.40% |
| Q3 2021 | 2021-09-30 | 0.23 | 0.05 | +26.57% |
| Q2 2021 · Jun 30 | 2021-06-30 | 0.25 | 0.07 | +35.63% |
| Q1 2021 · Mar 31 | 2021-03-31 | 0.26 | — | — |
| Q4 2020 · Dec 31 | 2020-12-31 | 0.18 | −12,997.20 | −100.00% |
| Q2 2021 · Sep 30 | 2020-09-30 | 0.18 | — | — |
| Q1 2021 · Jun 30 | 2020-06-30 | 0.19 | — | — |
| Q4 2019 · Dec 31 | 2019-12-31 | 12,997.38 | — | — |
Compass Therapeutics debt-to-assets ratio trends
Over the last five fiscal years, Compass Therapeutics's debt-to-assets ratio decreased from 0.18 to 0.04, a change of −0.14. The latest reported quarter, Q2 2026, shows 0.05.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Compass Therapeutics source filings ↗